Neoadjuvant chemo-immunotherapy: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
5
Conditions studied
0
US states with sites
2
Countries
Phase breakdown
Phase 1 1
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Mesothelioma; Pleura | 1 |
| Neoadjuvant Chemoimmunotherapy | 1 |
| Pleural Epithelioid Mesothelioma | 1 |
| Stage III Non-small Cell Lung Cancer | 1 |
Recruiting trials involving Neoadjuvant chemo-immunotherapy
- NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study
- Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy
Common questions
How many recruiting trials involve Neoadjuvant chemo-immunotherapy?
2 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.